← back to search

Zhiguang Zhou

Central South University · CN
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes and associated disorders, Pancreatic function and diabetes, Diabetes Management and Research, and Diabetes Treatment and Management.
h-index
69
citations
24,695
works
661
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and Safety of T Cell-Targeted Immunotherapy in Newly Diagnosed Type 1 Diabetes: A Systematic Review and Meta-Analysis.
2026cited by 0position: contributordoi
Health Inequities in Older Adults With Type 1 Diabetes: A Nationwide Registry Analysis of Sociodemographic and Clinical Profiles for Glycaemic Control and Complications.
2026cited by 0position: contributordoi
Fully automated insulin delivery systems in type 1 diabetes: A systematic review and meta-analysis.
2025cited by 4position: contributordoi
Intestinal mucosal immunity and type 1 diabetes: Non-negligible communication between gut and pancreas.
2025cited by 4position: contributordoi
A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population
Diabetologia 2025cited by 3position: lastdoi
Fatty Acid Binding Protein 4 Regulates the Antigen-Presenting Function of Dendritic Cells Resulting in T Cell Priming in Streptozotocin-Induced Type 1 Diabetes Mice.
2025cited by 1position: contributordoi
A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population.
2025cited by 1position: contributordoi
The protective role of TIGIT+ B cells in attenuating type 1 diabetes progression.
2025cited by 0position: contributordoi
The CCL20-integrin α5β1 interaction enhances TGF-β/Smad signaling to promote fibroblast activation in pulmonary fibrosis.
2025cited by 0position: contributordoi
TGF-β-mediated crosstalk between TIGIT+ Tregs and CD226+CD8+ T cells in the progression and remission of type 1 diabetes
Nature Communications 2024cited by 22position: middledoi
Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition).
2024cited by 19position: contributordoi
TGF-β-mediated crosstalk between TIGIT<sup>+</sup> Tregs and CD226<sup>+</sup>CD8<sup>+</sup> T cells in the progression and remission of type 1 diabetes.
2024cited by 18position: contributordoi
MODY Probability Calculator Is Suitable for MODY Screening in China: A Population-based Study.
2024cited by 7position: contributordoi
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals.
2024cited by 5position: contributordoi
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trial
The Lancet Regional Health - Western Pacific 2024cited by 5position: contributordoi
Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large-scale bidirectional Mendelian randomization and external validation study.
2024cited by 4position: contributordoi
Hsa_circRNA_405498 and hsa_circRNA_100033 Serve as Potential Biomarkers for Differential Diagnosis of Type 1 Diabetes.
2024cited by 4position: contributordoi
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia.
2024cited by 3position: contributordoi
Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double-blind phase 3 study.
2024cited by 2position: contributordoi
Myo9b mutations are associated with altered dendritic cell functions and increased susceptibility to autoimmune diabetes onset
Nature Communications 2023cited by 11position: middledoi
The Prevalence of Metabolically Unhealthy Normal Weight and Its Influence on the Risk of Diabetes.
2023cited by 10position: contributordoi
Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability.
2023cited by 10position: contributordoi
Weight loss and metabolic benefits of bariatric surgery in China: A multicenter study.
2023cited by 8position: contributordoi
Fat-to-muscle ratio is associated with insulin resistance and cardiometabolic disorders in adults with type 1 diabetes mellitus.
2023cited by 8position: contributordoi
HLA Class I Association With Autoimmune Diabetes in Chinese People: Distinct Implications in Classic Type 1 Diabetes and LADA.
2023cited by 7position: contributordoi
Type 2 Diabetes Family History as a Significant Index on the Clinical Heterogeneity Differentiation in Type 1 Diabetes.
2023cited by 5position: contributordoi
The impact of family history of type 2 diabetes on clinical heterogeneity in idiopathic type 1 diabetes.
2023cited by 5position: contributordoi
The Application Potential of Large Language Model in the Management for Diabetic Ketoacidosis: Systematic Review (Preprint)
2023cited by 0position: contributordoi
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
The Lancet Diabetes & Endocrinology 2022cited by 1,067position: middledoi
The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions
Diabetes Care 2022cited by 128position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 84 papers (2019–2026)Xia Li · Shanghai University33 papers (2014–2026) · 26 papers (2019–2026)Jianping Weng · University of Science and Technology of China24 papers (2013–2023)Weiping Jia · The Fourth People's Hospital20 papers (2013–2019)Wenying Yang · Nanchang Institute of Technology18 papers (2013–2017)Xiaohui Guo · Shandong University17 papers (2013–2019)Juming Lu · Chinese PLA General Hospital17 papers (2013–2019)Zhongyan Shan · Johannes Gutenberg University Mainz17 papers (2013–2018)Haoming Tian · Sichuan University17 papers (2013–2017) · 14 papers (2013–2019) · 14 papers (2013–2017)Linong Ji · SAIC-GM (China)13 papers (2013–2019) · 11 papers (2013–2015)Dalong Zhu · Nanjing Medical University10 papers (2013–2019)Dalong Zhu · Xinjiang Medical University10 papers (2012–2019)Zhigang Zhao · Hebei Medical University9 papers (2013–2016)Guangliang Shan · Chinese Academy of Medical Sciences & Peking Union Medical College9 papers (2013–2014)Li Chen · Wuhan Institute of Technology9 papers (2013–2019)Zhiguo Xie · Elsevier, Inc.8 papers (2022–2026)